Table 2 Patient characteristics for the surgical and radiotherapy cohorts
| Â | Data quality analysis cohorts | Survival analysis cohorts | ||||
|---|---|---|---|---|---|---|
All radiotherapy | Surgical | Radical radiotherapy | Radical cystectomy | |||
n = 525 | n = 206 | Chemoradiation n = 66 | Radiotherapy alone n = 270 | All n = 335 | ||
Number of patients (%) | ||||||
Age at 1st treatment | Median (IQR) | 75 (68–94) | 66.5 (56–73) | 75 (67–79) | 76.5 (70–82) | 68 (62–74) |
Range | 31–96 | 22–85 | 52–90 | 42–94 | 23–86 | |
Gender | Male | 380 (72.4%) | 147 (71.4%) | 47 (71.2%) | 200 (74.1%) | 248 (74.0%) |
Female | 144 (27.4%) | 59 (28.6%) | 19 (28.8%) | 70 (25.9%) | 87 (26.0%) | |
Ethnicity | White | 401 (76.4%) | 191 (92.7%) | 53 (80.3%) | 203 (75.2%) | 304 (90.7%) |
Asian/Asian British | 18 (3.4%) | 9 (4.4%) | 2 (3.0%) | 9 (3.3%) | 17 (5.1%) | |
Black/Black British | 5 (1.0%) | 3 (1.5%) | 0 (0.0%) | 4 (1.5%) | 1 (0.3%) | |
Mixed | 7 (1.3%) | 0 (0.0%) | 2 (3.0%) | 3 (1.1%) | 1 (0.3%) | |
Other | 2 (0.4%) | 2 (1.0%) | 1 (1.5%) | 0 (0.0%) | 2 (0.6%) | |
Unknown | 91 (17.3%) | 1 (0.5%) | 8 (12.1%) | 51 (18.9%) | 10 (3%) | |
Charlson score | < 1 | 253 (48.2%) | 116 (56.3%) | 33 (50.0%) | 125 (46.3%) | 216 (64.5%) |
1–5 | 73 (13.9%) | 45 (21.8%) | 14 (21.2%) | 31 (11.5%) | 55 (16.4%) | |
6–10 | 39 (7.4%) | 23 (11.2%) | 8 (12.1%) | 17 (6.3%) | 45 (13.4%) | |
11–15 | 21 (4.0%) | 10 (4.9%) | 3 (4.5%) | 7 (2.6%) | 12 (3.6%) | |
16–20 | 11 (2.1%) | 5 (2.4%) | 4 (6.1%) | 5 (1.9%) | 4 (1.2%) | |
> 20 | 8 (1.5%) | 3 (1.5%) | 0 (0.0%) | 4 (1.5%) | 3 (0.9%) | |
Unknown | 119 (22.7%) | 4 (1.9%) | 4 (6.1%) | 81 (30.0%) | 0 (0.0%) | |